JAK Inhibition and the Future of HS Treatment

The management of hidradenitis suppurativa (HS) is evolving, but many patients still face significant hurdles in achieving optimal outcomes with current therapies. In this episode, "JAK Inhibition and the Future of HS Treatment," expert dermatologists, Hadar Lev-Tov, MD, and Jennifer L. Hsiao, MD discuss: Increasing Awareness: Debunking common myths and misconceptions about HS. Building Trust:…